C. Efrata, T. 2016. R&D INTENSITY AND IPO UNDERPRICING: CASE STUDY ON PHARMACEUTICAL AND BIOTECH INDUSTRIES IN THE US. Journal of Accounting and Investment. 9, 1 (Feb. 2016), 1–21.